Cardlytics (CDLX) Asset Writedowns and Impairment (2017 - 2026)

Cardlytics' Asset Writedowns and Impairment history runs 10 years deep, the most recent figure standing at $335000.0 for Q1 2026.

• Quarterly Asset Writedowns and Impairment fell 47.9% year-over-year to $335000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $60.4 million (down 55.09% YoY) and the FY2025 annual result came in at $58.8 million, down 55.28% from the prior year.
• Asset Writedowns and Impairment was $335000.0 for Q1 2026 at Cardlytics, down from $58.8 million in the prior quarter.
• Across five years, Asset Writedowns and Impairment topped out at $452.3 million in Q4 2022 and bottomed at -$246000.0 in Q1 2023.
• A 5-year average of $48.0 million and a median of $990000.0 in 2023 frame the typical range for Asset Writedowns and Impairment.
• Annual changes were most pronounced in 2023 — Asset Writedowns and Impairment sank 171.1% — and 2024, when it soared 32074.82%.
• Cardlytics' Asset Writedowns and Impairment stood at $452.3 million in 2022, then plunged by 84.67% to $69.4 million in 2023, then jumped by 89.71% to $131.6 million in 2024, then tumbled by 55.28% to $58.8 million in 2025, then sank by 99.43% to $335000.0 in 2026.
• Business Quant data shows CDLX's Asset Writedowns and Impairment at $335000.0 in Q1 2026, $58.8 million in Q3 2025, and $1.2 million in Q2 2025.